In Brief: Vitamin B2/migraine study
This article was originally published in The Tan Sheet
Executive Summary
Vitamin B2/migraine study: Riboflavin (vitamin B2) "is an interesting option for migraine prophylaxis and a candidate for a comparative trial with an established prophylactic drug," J. Schoenen, MD, University of Liege, Belgium, et al., conclude in a three-month, 55-subject study published in the February issue of Neurology. Riboflavin at the 400 mg dosage tested "was superior to placebo in reducing attack frequency and headache days," the study says. Three "minor" adverse events occurred -- two (diarrhea and polyuria) in the riboflavin group and one (abdominal cramps) among those on placebo, Schoenen et al. note...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning